Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01841437 · ClinicalTrials.gov registry record
Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry
A clinical trial, sponsored by Glaukos Corporation.
- Completed
- Registry status
- 191
- Enrollment target
NCT01841437 is a clinical trial that has completed, run by Glaukos Corporation. The registered enrollment target is 191 participants.
The verdict
NCT01841437 has completed, sponsored by Glaukos Corporation.
- COMPLETED
- Registry status
- 191 participants
- Enrollment target
Study Summary
The purpose of this study is to observe the safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery in subjects with mild to moderate open-angle glaucoma.
Interventions
- DEVICE iStent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-06-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01841437
The ClinicalTrials.gov registry entry for NCT01841437 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iStent is the first listed.
NCT01841437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01841437 about?
NCT01841437 is a clinical study titled "Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry". The purpose of this study is to observe the safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery in subjects with mild to moderate open-angle glaucoma.
What is the current status of trial NCT01841437?
This trial is currently completed. The enrollment target is 191 participants. The study started on 2013-09. Estimated completion is 2016-06-21.
What interventions are being tested in trial NCT01841437?
The interventions under investigation include: iStent (DEVICE).
Who is sponsoring clinical trial NCT01841437?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.